Image For Representation

Biocon gets approval for use of CytoSorb to treat critical COVID-19 patients

New Delhi: Biocon Biologics has received DCGI approval for emergency use of CytoSorb to treat critical COVID-19 patients. The US Food and Drug Administration (USFDA) had recently approved CytoSorb for emergency use in COVID-19 patients. Biocon Ltd. announced on Wednesday that its subsidiary Biocon Biologics has received the Drugs Controller General of India’s (DCGI) approval for […]